The Hook
On October 28, the long-teased “AI Super Chip” event finally went live, and it delivered exactly what the teasers promised: a two-and-a-half-hour presentation that, in Stock Gumshoe’s dry accounting, was “extremely repetitive” and “essentially void of any further detail.” The event is co-signed by the editor of Brownstone Research’s Near Future Report and Whitney Tilson of Empire Financial Research, and it has been promoted for weeks under a pair of escalating deadlines. The pre-event teardown covers the teaser itself and the Innodata and Cerebras reveals that surfaced before the event aired; this article follows the one genuinely new item the event produced.
The ad copy set the frame. “October 28 could open the AI investment opportunity of the decade,” it read, promising “a breakthrough new AI firm whose chip is 50 times faster than Nvidia’s” and a roster of “little-known stocks” that would “replace the Magnificent 7.” There are two deadlines at play: October 28 to sign up for the presentation, and November 5 to buy. That countdown structure is the conversion engine, and it worked: the event is now a real, recorded thing.
The one genuinely new item to come out of the event is a free stock pick, and that pick deserves a close look on its own merits, because the pick and the pitch are aimed at two different companies.
The Big Claim
The “AI Super Chip” itself is Cerebras, the wafer-scale-engine builder, and it is not new ground. The “50X faster than Nvidia” and “144X more powerful than Qualcomm” figures are the same benchmark-specific claims this duo ran in their May 2025 event, and the core thesis is unchanged: a chip so much faster and cheaper to run that it will crown a new group of software and services companies, a “Fabulous Five” that will supposedly “lead you to dot-com-like gains of 1,000% or more.” We have covered Cerebras separately on this site, so this teardown sets that thread aside.
The fresh reveal from the October 28 update is Synopsys (SNPS), handed out as a free recommendation in the presenter’s own words: “My free recommendation today is Synopsys (SNPS)… Buy the stock now.” That is the specific, nameable thing a reader walks away with, and it is what the rest of this article checks.
The Mechanism
To understand why Synopsys is even in this pitch, you have to understand what Synopsys actually does, because it is not a chip company in the way Cerebras is. Synopsys makes the software that chip designers use to build every other chip. Our EDA explainer covers the details; the short version is below.
Electronic design automation, or EDA, is the “picks and shovels” layer of the semiconductor industry. Before a chip like Cerebras’s wafer-scale engine or Nvidia’s next GPU can be fabricated, an engineering team has to design, simulate, and verify billions of transistors and the interconnects between them. That work is done in EDA tools, and Synopsys, alongside Cadence Design Systems, is one of the two companies that effectively own this market. Stock Gumshoe calls it “the chip-design-software duopoly,” and that is exactly right. If you want the side-by-side on the two, our Cadence vs Synopsys comparison has it.
The AI angle is real and worth spelling out. Every generation of chips gets harder to design: smaller process nodes, more complex architectures, chiplets, and custom accelerators all multiply the design problem, and the software that solves that problem becomes more valuable, not less. When the pitch says Synopsys is “critical to building out a world run by next-gen AI,” there is genuine logic there. You cannot build an AI super chip without EDA software, and Synopsys sells that software to essentially everyone. The company also licenses reusable semiconductor intellectual-property blocks, the building-block designs that chipmakers drop into their own products to save time.
So the mechanism is sound. Synopsys genuinely sits upstream of every AI chip. The question is whether that makes it the “1,000%” rocket the broader pitch implies, and the answer is no, for reasons that are mostly about what Synopsys already is.
The Real Pick
Current prices are as of the October 27, 2026 close, from Polygon.
| Ticker | Company | Tease Price | Current Price | Change Since Tease |
|---|---|---|---|---|
| SNPS | Synopsys Inc | $474.42 | $474.42 | +0.00% |
The zero percent change is honest and important. Synopsys was named as a free recommendation today, so the tease price and the current price are the same number. Unlike the other names in this event’s teaser table, Innodata down 24.67% and Cerebras up 7.66%, there is no historical tease to measure against. Synopsys carries a market capitalization of roughly $91 billion and about 28,000 employees. This is a large, established franchise, not a “little-known” one.
Does the Math Check Out?
Let us put numbers next to the framing, starting with the word “little-known.” Synopsys is a $91 billion company. It is one half of a global duopoly. It has been public since 1992 and is a household name to anyone who follows semiconductors. The “Fabulous Five… little-known stocks” language is doing the heavy lifting for the pitch, but Synopsys is not in that category, and presenting it as a hidden opportunity is a category error.
The valuation claim is worth a second look too. Stock Gumshoe pegs Synopsys at “about 27X forward earnings, after peaking in the 40s when enthusiasm was a little higher.” That is a real, concrete number, and it tells a nuanced story. On the one hand, 27 times forward earnings is far from a value price for a company whose stock “hasn’t done much in the past couple years.” On the other hand, the compression from the 40s to the 27s reflects a stock that has already de-rated significantly while the underlying franchise kept growing. There is a reasonable case that the market has already priced out a good deal of the excess enthusiasm.
The headline chip claims deserve the same scrutiny Stock Gumshoe has applied for a year and a half. “50X faster than Nvidia” and “144X more powerful than Qualcomm” are benchmark-specific figures measured on narrow inference workloads, not general capability. The chip is genuinely impressive. The numbers are marketing. More to the point, those claims are about Cerebras, not about Synopsys, so even taken at face value they do not transfer to the free pick being recommended.
The most telling detail is what the event did not say. The “Fabulous Five,” the actual core of the pitch, were never named, just as the May 2025 version held them back until after the summit. Last time the five turned out to be Vertiv, GitLab, UiPath, Symbotic, and Certara. That is a real track record worth remembering: the pitch’s headline promise is a list of five stocks that were never revealed at the event and still are not.
What They Got Right
- The mechanism is legitimate. EDA software is genuinely critical to building AI chips, and Synopsys genuinely sits upstream of the entire semiconductor industry. This is not a stretched analogy; it is the actual supply chain.
- The pick itself is high quality. Synopsys is one half of a duopoly with a durable competitive moat, high margins, and real exposure to rising chip-design complexity. This is the opposite of a fly-by-night promo stock.
- The “avoid Anthropic” note shows independent thinking. Setting aside whether you agree, a pitch that goes out of its way to argue against the most-hyped IPO of the year is at least not blindly chasing consensus.
- The valuation framing is more honest than most promos. At roughly 27 times forward earnings after de-rating from the 40s, the stock is not being presented as a bargain, and the market has already removed much of the froth.
- The historical continuity is real. This is a re-run of a May 2025 event, and the structural logic, hardware first, then software and services, is a coherent framework that has been applied consistently.
What They Got Wrong
- “Little-known” does not describe a $91 billion duopoly leader. The category error implies “undiscovered and cheap” when Synopsys is neither, and it quietly borrows the excitement of the genuinely small “Fabulous Five” names for a large cap.
- The “1,000% or more” framing is attached to the wrong stock. The headline return promise is about five unnamed companies, while the only concrete free pick is a mature large cap that has been flat for two years.
- The “Fabulous Five” were still never named at the event. The single most important part of the pitch, the list of stocks that will supposedly replace the Magnificent 7, remains unverifiable after the event concluded.
- The chip-specification numbers are benchmark-specific and do not transfer. “50X faster than Nvidia” is about Cerebras, and even there it is a narrow inference-workload claim, not a general capability statement.
- The “buy now” urgency does not match the opportunity. A quality compounder at 27 times forward earnings is not the kind of pick that requires a November 5 deadline to capture; that urgency is about the subscription funnel, not the stock.
The Verdict
Synopsys is a high-quality franchise wrapped in a pitch that oversells what it is. If you want durable, high-margin exposure to the semiconductor buildout without betting on any single chip architecture, Synopsys is a genuinely reasonable way to get it: the EDA duopoly is one of the best business models in the industry, and the AI buildout is a real, observable driver of demand for design software. But this is a “buy at the right price” story about a quality compounder, not a “buy by November 5 before it 10-bags” story. Anyone buying Synopsys because of the “Fabulous Five” framing is buying the wrong thesis. Evaluate it as what it is: a dominant, fairly-valued franchise with a steady, if unspectacular, growth profile.
This is not financial advice. NewsletterVetter has no position in any stock mentioned. The teaser’s own fine print, which we always read, carries the standard disclosure that advertised results are not guarantees and that individual outcomes will vary. Always do your own research before acting on any pitch.